HCV recurrence in HIV-infected patients after liver Transplant

Journal of the International Association of Physicians in AIDS Care

Volumn 9, Issue 2, 2010, Pages 87-93

  Hughes, Christopher B ^a   Dickson, Rolland C ^b   Krishna, Murli ^c   Willingham, Darrin L ^c   Satyanarayana, Raj ^c   Harnois, Denise M ^c   Keaveny, Andrew P ^c   Rosser, Barry ^c   Aranda Michel, Jaime ^c   Kramer, David J ^c   Hellinger, Walter ^c   Mendez, Julio ^c  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^c MAYO CLINIC   (United States)

Author keywords

Hepatitis C virus; HIV AIDS; Ishak score; Liver transplantation; Pegylated interferon

Indexed keywords

ABACAVIR; CONSENSUS INTERFERON; EFAVIRENZ; EMTRICITABINE; LAMIVUDINE; LOPINAVIR PLUS RITONAVIR; NELFINAVIR; PEGINTERFERON ALPHA2B; RIBAVIRIN; STAVUDINE; ZIDOVUDINE;

ADULT; ARTICLE; CLINICAL ARTICLE; DRUG DOSE INCREASE; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER BIOPSY; LIVER FAILURE; LIVER FIBROSIS; LIVER TRANSPLANTATION; MIXED INFECTION; MORTALITY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RECURRENT DISEASE; SURVIVAL RATE; TREATMENT RESPONSE;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIVIRAL AGENTS; BIOPSY; HEPACIVIRUS; HEPATITIS C; HIV INFECTIONS; HUMANS; LIVER; LIVER FAILURE; LIVER TRANSPLANTATION; MIDDLE AGED; RECURRENCE; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 77953666906     PISSN: 15451097     EISSN: 15570886     Source Type: Journal    
DOI: 10.1177/1545109710362592     Document Type: Article

References (36)

1. Palella JF, Delaney KM, Mooman AC. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Eng J Med. 1998;338(13):853
2. Anderson R. Double Trouble: Hepatitis and HIV Coinfections Require Special Attention (Data from CHORUS Database). LifeGuide A&U 2000; 59
3. Alter MJ, Kruszon-Moran D, Nainan OV, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Eng J Med. 1999;341(8):556-562
4. Sherman KE, Rouster SD, Chung RT, Rajicic N. Hepatitis C virus prevalence among patients infected with human immunodeficiency virus: A cross-sectional analysis of the US Adult AIDS Clinical Trials Group. Clini Infect Dis. 2002;34(6):831-837
5. Troisi C, Hollinger FB, Hoots W, et al. A multicenter study of viral hepatitis in a United States hemophiliac population. Blood. 1993;81(2):412-418
6. Berenguer M, Wright TL. Hepatitis C and liver transplantation. Gut. 1999;45(2):159
7. Everhart JE, Wei Y, Eng H, et al. Recurrent and new hepatitis C virus infection after liver transplantation [published erratum appears in Hepatology 1999 Oct;30(4):1110]. Hepatology. 1999;29(4):1220-1226
8. Eyster ME, Fried MW, Di Bisceglie AM, Goedert JJ. Increasing hepatitis C virus RNA levels in hemophiliacs: relationship to human immunodeficiency virus infection and liver disease. Multi-center Hemophilia Cohort Study. Blood. 1994;84(4):1020-1023
9. Norris S, Taylor C, Muiesan P, et al. Outcomes of liver transplantation in HIV-infection individuals: the impact of HCV and HBV infection. Liver Transpl. 2004;10(10):1271-1278
10. Neff GW, Bonham A, Tzakis AG, et al. Orthotopic liver transplantation in patients with human immunodeficiency virus and end-stage liver disease. Liver Transpl. 2003;9(3):239-247
11. Castells L, Escartin A, Bilbao I, et al. Liver transplantation in HIV-HCV coinfected patients: a case-control study. Transplantation. 2007;83(3):354-358
12. de Vera ME, Dvorchik I, Tom K, et al. Survival of liver transplant patients coinfected with HIV and HCV is adversely impacted by recurrent hepatitis C. Am J Transplant. 2006;6(12):2983-2993
13. Prachalias AA, Pozniak A, Taylor C, et al. Liver transplantation in adults coinfected with HIV. Transplantation. 2001;72(10): 1684-1688
14. Schvarcz R, Soderdahl G. Successful hepatitis C virus treatment in patients coinfected with HIV after liver transplantation. Transplantation. 2005;79(7):853
15. Ishak K, Baptista A, Bianchi L, et al. Histologic grading and staging of chronic hepatitis. J Hepatol. 1995;22(6):696-699
16. Ormonde DG, de Boer WB, Kierath A, et al. Banff criteria for grading liver allograft rejection: utility in clinical practice. Liver Trans Surg. 1999;5(4):261-268
17. Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet. 1997; 349(9055):825-832
18. Kenny-Walsh E. Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group. N Engl J Med. 1999;340(16):1228-1233
19. Mohsen AH, Easterbrook PJ, Taylor C, et al. Impact of human immunodeficiency virus (HIV) infection on the progression of liver fibrosis in hepatitis C virus infected patients. Gut. 2003; 52(7):1035-1040
20. Poynard T, Mathurin P, Lai CL, et al. A comparison of fibrosis progression in chronic liver diseases. J Hepatol. 2003;38(3): 257-265
21. Benhamou Y, Bochet M, Di Martino V, et al. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group. Hepatology. 1999; 30(4):1054-1058 (Pubitemid 29458296)
22. Graham CS, Baden LR, Yu E, et al. Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis. Clin Infect Dis. 2001;33(4):562-569
23. Ghany MG, Leissinger C, Lagier R, Sanchez-Pescador R, Lok AS. Effect of human immunodeficiency virus infection on hepatitis C virus infection in hemophiliacs. Dig Dis Sci. 1996; 41(6):1265-1272
24. Sherman KE, O'Brien J, Gutierrez AG, et al. Quantitative evaluation of hepatitis C virus RNA in patients with concurrent human immunodeficiency virus infections. J Clin Microbiol. 1993; 31(10):2679-2682
25. Thomas DL, Shih JW, Alter HJ, Vlahov D, Cohn S, Hoover DR, Cheung L, Nelson KE. Effect of human immunodeficiency virus on hepatitis C virus infection among injecting drug users. J Infect Dis. 1996;174(4):690-695 (Pubitemid 26325882)
26. Eyster ME, Fried MW, Di Bisceglie AM, Goedert JJ. Increasing hepatitis C virus RNA levels in hemophiliacs: relationship of human immunodeficiency virus infection and liver disease. Multicenter Hemophilia Cohort Study. Blood. 1994;84(4): 1020-1023
27. Beld M, Penning M, Lukashov V, et al. Evidence that both HIV and HIV-induced immunodeficiency enhance HCV replication among HCV seroconverters. Virology. 1998;244(2): 504-512
28. Chung RT, Anderson J, Volberding P, et al. Peginterferon alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons. N Engl J Med. 2004; 351(5):451-459
29. Torriani FJ, Rodriguez-Torres M, Rockstroh JK, et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients. N Engl J Med. 2004;351(5):438-450
30. Perronne C, Carrat F, Bani-Sadr F, et al. Final results of ANRS HC02-RIBAVIC: a randomized controlled trial of peglyated interferon-alfa-2b plus ribavirin vs. interferon alfa-2b plus ribavirin for the initial treatment of chronic hepatitis C in HIV coinfected patients [abstract 686]. In: Program and Abstracts of the 11th Conference on Retroviruses and Opportunistic Infections (San Francisco). 8-11 Feb 2004. Abstract 177LB. Alexandra, VA: Foundation for Retrovirology and Human Health; 2004: 545
31. Carrat F, Bani-Sadr F, Pol S, et al. Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial. JAMA. 2004;292(23):2839- 2848
32. Ferenci P. Predictors of response to therapy for chronic hepatitis C. Semin Liver Dis. 2004;24(suppl 2):25-31
33. Laguno M, Murillas J, Blanco JL, et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for treatment of HIV/HCV coinfected patients. AIDS. 2004;18(13): F27-F36
34. Fauci AS, Schnittman SM, Poli G, Koenig S, Pantaleo G. Immunopathogenetic mechanisms in human immunodeficiency virus (HIV) infection. Ann Intern Med. 1991;114(8):678-693
35. Ragni MV, Belle SH. Impact of human immunodeficiency virus infection on progression of end-stage liver disease in individuals with hemophilia and hepatitis C virus infection. J Infect Dis. 2001;183(7):112-115
36. Matthews GV, Dore GJ. HIV and hepatitis C confection. J Gastroenterol Hepatol. 2008;23(7 Pt 1):1000-1008